Why a factory-made peptide spray differs from a vial

What a formulated aqueous peptide product contains (buffer, tonicity agent, preservative), how preservative efficacy is tested under USP <51>, why formulated products carry an in-use period, and what a dissolving strip is made of.

By Touchstone PeptidesSeptember 22, 20269 minute read

A lyophilized vial contains a peptide and its counter-ion. A factory-made spray contains the same peptide dissolved in a designed solution: a buffer that holds the pH where the peptide degrades slowest, a tonicity agent, a preservative that has passed an antimicrobial effectiveness test, and water of a specified grade. Those additions are why a formulated product is tested differently, documented differently and labelled with an in-use period. This piece describes the catalog's liquid sprays, such as Selank liquid spray, and dissolving strips, such as NAD+ strips, as formats only.

What is in a vial, and what is in a formulated solution

Read three approved peptide nasal solution labels on DailyMed and the pattern is the same. Calcitonin salmon nasal spray lists "benzalkonium chloride, hydrochloric acid (added as necessary to adjust pH), purified water and sodium chloride." Desmopressin nasal spray lists "benzalkonium chloride solution, citric acid monohydrate, sodium chloride, sodium phosphate dibasic heptahydrate, and purified water." Nafarelin (Synarel) lists "benzalkonium chloride, glacial acetic acid, sodium hydroxide or hydrochloric acid (to adjust pH), sorbitol, and purified water."

Each list has four jobs in it: a pH system (citrate and phosphate; acetic acid with base; or a mineral acid to set pH), a tonicity agent (sodium chloride or sorbitol), a preservative (benzalkonium chloride in all three), and water. The peptide is one line among five or six. That is the difference in kind between a vial and a spray. The vial is a raw material whose only variables are purity, content and counter-ion (what lyophilized means); the spray is a formulation in which every excipient was chosen for that peptide and then tested with it.

The buffer and the pH

A peptide in water degrades at a rate that depends on pH, and the dependence is not monotonic. Deamidation, cleavage after aspartate, cysteine oxidation and aggregation each follow their own pH profile; the residue chemistry is set out in freeze-thaw, aliquots and oxidation.

Somewhere between those competing curves is a minimum, different for every sequence, and the buffer's job is to hold the solution there for the product's whole shelf life. Manufacturer guidance for research solutions points in the same direction: GenScript's guide suggests buffers "at pH 5-6" for peptides that must be kept in solution at all. A formulated product goes further and picks the exact pH from stability data on that peptide, then chooses a buffer species with a pKa near it. Citrate, phosphate and acetate appear on the three labels above for that reason, and the buffer's concentration is set to resist the drift that a trace of acid or base, or of carbon dioxide from the headspace, would otherwise cause.

Tonicity

A tonicity agent brings the solution's osmolality to a specified value; sodium chloride is the usual choice and sorbitol a common alternative, as the labels show. For the peptide, the agent's ionic strength is not neutral: dissolved salt screens the charges that keep peptide chains apart, which is one of the variables Zapadka's review lists as controlling aggregation rate. A formulator therefore chooses between an ionic agent and a non-ionic one with the peptide's aggregation behaviour in mind.

The preservative, and how its efficacy is tested

A solution in a multidose container is opened to air repeatedly, and every opening can introduce microorganisms. An unpreserved peptide solution is a growth medium. The preservative's job is to keep any such contamination from establishing itself, and it is not assumed to work: it is tested.

The compendial test is USP General Chapter <51>, Antimicrobial Effectiveness Testing. The product is inoculated with five defined organisms, two bacteria of one type, one of another, a yeast and a mould (Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Aspergillus brasiliensis, formerly A. niger), and sampled over 28 days. The acceptance criteria depend on the product category. In the chapter's classification, parenteral products, otic products, "sterile nasal products, and ophthalmic products made with aqueous bases or vehicles" are Category 1; "topically used products made with aqueous bases or vehicles, nonsterile nasal products, and emulsions" are Category 2; oral aqueous products are Category 3. A 2023 paper in Cureus applying the chapter to a Category 1 product states the bacterial criteria: "no less than 1.0 Log10 reduction from the initial inoculum count at 7 days, not less than 3.0 Log10 reduction from the initial inoculum count at 14 days, and no increase from the 14 day's viability sampling interval count at 28 days," while for yeast and mould the requirement is "no increase from the initial inoculum count at 7, 14, and 28 days." Category 2 asks for a 2.0 log bacterial reduction by day 14 and no increase thereafter.

Benzalkonium chloride is the preservative on all three labels above; chlorobutanol, benzyl alcohol and m-cresol are the other names that recur in peptide products. Which is chosen depends partly on the peptide.

Preservatives can interact with the peptide

A preservative is a small reactive molecule added to a solution of a larger reactive molecule, and they can interact. Li and colleagues at Merck studied a 31-residue acylated peptide by NMR and found that "the addition of benzyl alcohol does not induce aggregation" of it, whereas 1% (w/v) m-cresol gave "insoluble aggregates composed of 25% (w/w) peptides after a 24-hour incubation at room temperature," with the preservative binding at specific residues: "Met, Lys, Glu, and Gln." The same peptide, two preservatives, opposite outcomes.

The salmon calcitonin literature shows the other side of the same question. When a nasal solution preserved with chlorobutanol was developed as an alternative to the benzalkonium chloride reference product, Costantino and colleagues had to demonstrate by mass spectrometry, circular dichroism, NMR, sedimentation velocity and size-exclusion chromatography that the peptide's structure and "aggregation state" were the same in both, including "at the end of recommended shelf storage" and in-use conditions. Changing the preservative is a change to the product, and it is proven equivalent, not assumed.

Why formulated products carry an in-use period

The number on a formulated product's label after "once opened" comes from a study, not a convention. The European guideline that defines it, CPMP/QWP/2934/99, states the purpose plainly: "to establish, where applicable, a period of time during which a multidose product can be used whilst retaining quality within an accepted specification once the container is opened." Its scope is products in multidose containers which, in the guideline's words:

due to repeated opening and closing, may pose a risk to its content with regard to microbiological contamination, proliferation and/or physico-chemical degradation once the closure system has been breached.EMEA, Note for Guidance on In-Use Stability Testing, CPMP/QWP/2934/99, 2001

The study simulates real use of the container over the proposed period and measures what can change: the guideline lists "active substance assay(s), antimicrobial preservative and antioxidant content(s), degradation product level(s), pH" on the chemical side, "colour, clarity, closure integrity, particulate matter" on the physical side, and "total viable count, sterility" on the microbial side. The period that passes all of them is the one on the label: "The in-use shelf life should be stated on the label." A lyophilized vial with no preservative and no formulation has no such study behind it, which is one reason the manufacturers' guides say what they say about unformulated solutions.

Container integrity is its own discipline. For sterile products, USP <1207>, Package Integrity Evaluation, sets out how a package's maximum allowable leakage limit is defined and how leak tests are chosen, with a stated preference for deterministic methods that "follow a predictable chain of events and can be controlled" over probabilistic ones. A pump bottle that is designed to be opened to air is not a sterile package, and the in-use study is the test that matches it.

What a dissolving strip is made of

A dissolving strip is a third format again: a solid, but a formulated one. The pharmaceutical literature calls it an orodispersible film. Jacob and colleagues' 2023 review lists the film-forming polymers: hydroxypropyl methylcellulose (HPMC) in several viscosity grades, sodium carboxymethylcellulose, gelatin, polyvinyl alcohol, polyethylene oxide, maltodextrins and pullulan, a polysaccharide. HPMC and gelatin are "the most commonly used." A plasticizer such as glycerol or PEG 400 is added because "plasticizers lower the glass-transition temperature of the polymers from a hard, glassy material to a soft, rubbery material," which is what keeps a strip from cracking. Sweeteners are used at "3 to 6% w/w," and organic acids such as citric acid at "3 to 5% by weight."

The films are made by solvent casting: polymer, plasticizer and active are dissolved or dispersed in a solvent, spread as a thin layer, dried, and cut. Takeuchi and colleagues describe HPMC and hydroxypropyl cellulose blends cast from an ethanol-water mixture and dried in an air current, and note that "film-forming polymers primarily dominate the properties of ODFs, making appropriate polymers crucial." The quality standards Jacob's review cites specify a film of about 2 x 2 cm and a maximum thickness of 100 µm that disintegrates in an in-vitro test in "not more than 60 s"; Takeuchi's blend films disintegrated in under 40 s.

Proteins have been formulated in such films: Jacob's review records ovalbumin, beta-galactosidase and lysozyme carried in pullulan films, with freeze-drying proving "more suitable for process stability" than heat drying. That is the relevant point for a peptide strip. The active is dispersed in a polymer matrix rather than dissolved in water, so the degradation chemistry of a wet solution does not apply in the same way, but the casting solvent, the drying step and the polymer's own moisture all become variables that a certificate for the finished strip has to cover.

Vial, spray or strip compares the three formats as catalog items; the certificate for a formulated product has to cover the excipients, pH, preservative content and degradation products, or for a film the polymer, moisture and disintegration test, which makes it a longer document than a vial's.

Sources

For laboratory research use only. Not a drug, not a supplement, and nothing here is a claim about what any of this material does in a person or an animal.

Two things before you come in.